Anuh Pharma Ltd.
National Stock Exchange of IndiaTotal Valuation
Anuh Pharma Ltd. carries a market capitalization of 7.90B, placing it among publicly traded companies globally. Its enterprise value stands at 6.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.90B |
| Enterprise Value | 6.18B |
Share Statistics
Anuh Pharma Ltd. currently has 100.22M shares outstanding.
| Shares Outstanding | 100.22M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Anuh Pharma Ltd. trades at a trailing price-to-earnings ratio of 16.37. The price-to-sales ratio is 0.87, and the price-to-book ratio stands at 13.41.
| PE Ratio | 16.37 |
| PS Ratio | 0.87 |
| PB Ratio | 13.41 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Anuh Pharma Ltd. trades at an EV/EBITDA multiple of 13.01 and an EV/FCF ratio of 1,728.02. The EV/Sales ratio of 0.80 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.01 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.80 |
| EV / EBITDA | 13.01 |
| EV / EBIT | 13.01 |
| EV / FCF | 1,728.02 |
Financial Position
Anuh Pharma Ltd. maintains a current ratio of 2.22, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.02, indicating conservative leverage, while an interest coverage ratio of 100.51 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.22 |
| Quick Ratio | 0.27 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | 100.51 |
Financial Efficiency
Anuh Pharma Ltd. posts a return on equity of 31.62 and a return on invested capital of 10.38.
| Return on Equity (ROE) | 31.62 |
| Return on Assets (ROA) | 7.72 |
| Return on Invested Capital (ROIC) | 10.38 |
| Return on Capital Employed (ROCE) | 30.61 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.40 |
Taxes
Over the trailing twelve months, Anuh Pharma Ltd. has paid 131.75M in income taxes, reflecting an effective tax rate of 24.30.
| Income Tax | 131.75M |
| Effective Tax Rate | 24.30 |
Stock Price Statistics
Anuh Pharma Ltd.'s stock has declined approximately -24.53065% over the past 52 weeks. The 50-day moving average sits at 78.80, while the 200-day moving average is 78.82.
| Beta (5Y) | N/A |
| 52-Week Price Change | -24.53065% |
| 50-Day Moving Average | 78.80 |
| 200-Day Moving Average | 78.82 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Anuh Pharma Ltd. generated 7.72B in revenue and converted that into 410.46M in net income, yielding earnings per share of 4.10. EBITDA reached 474.72M, while operating income came in at 474.72M.
| Revenue | 7.72B |
| Gross Profit | 1.72B |
| Operating Income | 474.72M |
| Pretax Income | 542.21M |
| Net Income | 410.46M |
| EBITDA | 474.72M |
| EBIT | 474.72M |
| Earnings Per Share (EPS) | 4.10 |
Balance Sheet
Anuh Pharma Ltd. holds 541.02M in cash and equivalents against 583,000.00 in total debt, resulting in a net debt position of -80.60M. Total book value stands at 501.12M, with working capital of 2.48B providing operational flexibility.
| Cash & Cash Equivalents | 541.02M |
| Total Debt | 583,000.00 |
| Net Debt | -80.60M |
| Equity (Book Value) | 501.12M |
| Book Value Per Share | 5.01 |
| Working Capital | 2.48B |
Margins
Anuh Pharma Ltd. operates with a gross margin of 22.29, reflecting its pricing power and cost economics. The operating margin of 6.15 and net profit margin of 5.32 provide insight into operational efficiency.
| Gross Margin | 22.29 |
| Operating Margin | 6.15 |
| Pretax Margin | 7.03 |
| Profit Margin | 5.32 |
| EBITDA Margin | 6.15 |
Scores
Anuh Pharma Ltd. posts an Altman Z-Score of 4.17, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.17 |